Rx revenue surged 12.2% year-over-year in Q3, with e-prescriptions driving growth and TeleClinic revenue doubling. Group external revenue rose 4.9% in local currency, and 2024 guidance for 5–10% revenue growth is confirmed.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.